Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Early aggressive therapy for severe extensive ulcerative colitis
World Journal of Gastroenterology, 09/14/09
Cui DJ – Although this therapeutic strategy may seem to be cost–efficient and reduce the risk of side effects, recent trials and case reports have shown that top–down therapy using infliximab induces a rapid clinical response, enhances patient quality of life, promotes mucosal healing, reduces surgeries and indirect cost of treatment for patients with severe UC. Moreover, since long–term treatment with infliximab is safe and well tolerated, early aggressive top–down therapeutic strategy may be a more effective approach, at least in a subgroup of severe extensive UC patients.
Related Articles
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 70%
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09
Relevance Score: 69%
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09
Relevance Score: 68%
Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09
Relevance Score: 68%
Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09
Relevance Score: 68%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09
Appendiceal Mucocele Detected under Treatment of Ulcerative Colitis
Case Reports in Gastroenterology, 11/25/09
Pyoderma Gangrenosum in Crohn's Disease: Unusual Presentation and Management
Case Reports in Gastroenterology, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09
Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
Cancer Chemotherapy and Pharmacology, 12/01/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


